Globus Medical Reports Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- L3Harris CEO steps down amid conduct review, shares drop
William Blair Downgrades Globus Medical (GMED) to Market Perform
November 9, 2016 7:30 AM ESTWilliam Blair downgraded Globus Medical (NYSE: GMED) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $22.33 yesterday.
... MoreOppenheimer Downgrades Globus Medical (GMED) to Perform
November 9, 2016 7:29 AM ESTOppenheimer downgraded Globus Medical (NYSE: GMED) from Outperform to Perform with a price target of $23.00 (from $29.00).
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $22.33 yesterday.
... MoreJMP Securities Downgrades Globus Medical (GMED) to Market Perform
November 9, 2016 6:46 AM ESTJMP Securities downgraded Globus Medical (NYSE: GMED) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $22.33 yesterday.
... MoreGlobus Medical (GMED) Reports In-Line Q3 EPS
November 8, 2016 4:22 PM ESTGlobus Medical (NYSE: GMED) reported Q3 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $135.7 million versus the consensus estimate of $139.25 million.
GUIDANCE:
Globus Medical sees FY2016 EPS of $1.20, versus the consensus of $1.20. Globus... More
